Trials / Completed
CompletedNCT06931327
To Evaluate the Safety and Pharmacokinetic Characteristics of AJU-C711 in Healthy Adults
An Open Label, Randomized, Single Dose, 2-sequence, 2-period, Cross-over Phase 1 Study to Evaluate Bioequivalence of AJU-C711 Compared to C711R in Healthy Adult Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- AJU Pharm Co., Ltd. · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Accepted
Summary
To evaluate the safety and pharmacokinetic characteristics of AJU-C711 in healthy adults
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Test Drug | AJU-C711 |
| DRUG | Reference Drug | C711R |
Timeline
- Start date
- 2025-03-29
- Primary completion
- 2025-04-16
- Completion
- 2025-04-18
- First posted
- 2025-04-17
- Last updated
- 2025-06-12
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT06931327. Inclusion in this directory is not an endorsement.